journal
Journals European Journal of Clinical P...

European Journal of Clinical Pharmacology

https://read.qxmd.com/read/39254692/the-cost-effectiveness-analysis-of-semaglutide-for-the-treatment-of-adult-and-adolescent-patients-with-overweight-and-obesity-a-systematic-review
#1
REVIEW
Ali Sarabi Asiabar, Mohammad Ali Rezaei, Dariush Jafarzadeh, Soheila Rajaei, Pezhman Atefimanesh, Samira Soleimanpour, Mohammad Hossein Kafaei Meher, Samad Azari
PURPOSE: The present study aimed to systematically collect and synthesize available cost-effectiveness studies of semaglutide in patients with obesity or overweight in comparison with other interventions. METHODS: We comprehensively searched multiple electronic databases to identify relevant literature. Studies were selected based on inclusion and exclusion criteria. The quality of studies was appraised using the "Consolidated Health Economic Evaluation Reporting Standards" (CHEERS) tool...
September 10, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39251431/chatgpt-does-make-up-scientific-references-should-it-be-currently-renamed-cheatgpt
#2
LETTER
Gerd Mikus
No abstract text is available yet for this article.
September 10, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39249114/approaches-for-posaconazole-therapeutic-drug-monitoring-and-their-clinical-benefits
#3
REVIEW
Silu Wang, Changkun Li, Yalin Dong, Weihua Dong
OBJECTIVE: This review examines the progress of research on posaconazole therapeutic drug monitoring (TDM) that has focused on differences in the TDM of posaconazole after clinical application in different formulations and in different populations, the factors that affect posaconazole concentrations, the advantages of posaconazole TDM in terms of clinical efficacy and cost savings, and measurement methods. METHODS: A literature search (2006 to 2024) was performed in PubMed and Embase with the following search terms: noxafil, posaconazole hydrate, posaconazole, drug monitoring, therapeutic drug monitoring, and TDM...
September 9, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39240338/voriconazole-therapeutic-drug-monitoring-including-analysis-of-cyp2c19-phenotype-in-immunocompromised-pediatric-patients-with-invasive-fungal-infections
#4
JOURNAL ARTICLE
Matylda Resztak, Paulina Zalewska, Jacek Wachowiak, Agnieszka Sobkowiak-Sobierajska, Franciszek K Główka
PURPOSE: Therapeutic drug monitoring (TDM) of voriconazole (VCZ) should be mandatory for all pediatric patients with invasive fungal infections (IFIs). The narrow therapeutic index, inter-individual variability in VCZ pharmacokinetics, and genetic polymorphisms cause achieving therapeutic concentration during therapy to be challenging in this population. METHODS: The study included 44 children suffering from IFIs treated with VCZ. Trough concentrations (Ctrough ) of VCZ ware determined by the HPLC-FLD method...
September 6, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39240337/therapeutic-drug-monitoring-in-tuberculosis
#5
REVIEW
M Sarkar, J Sarkar
PURPOSE: Therapeutic drug monitoring (TDM) is a standard clinical procedure that uses the pharmacokinetic and pharmacodynamic parameters of the drug in the body to determine the optimal dose. The pharmacokinetic variability of the drug(s) is a significant contributor to poor treatment outcomes, including the development of acquired drug resistance. TDM aids in dose optimization and improves outcomes while lessening drug toxicity. TDM is used to manage patients with tuberculosis (TB) who exhibit a slow response to therapy, despite good compliance and drug-susceptible organisms...
September 6, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39210212/fixed-parameters-in-the-population-pharmacokinetic-modeling-of-valproic-acid-might-not-be-suitable-external-validation-in-chinese-adults-with-epilepsy-or-after-neurosurgery
#6
JOURNAL ARTICLE
Ruoyun Wu, Kai Li, Zhigang Zhao, Shenghui Mei
PURPOSE: This study aims to assess the predictive performance of published valproic acid (VPA) population pharmacokinetic (PPK) models using an external data set in Chinese adults with epilepsy or after neurosurgery. METHODS: A total of 384 concentrations from 290 Chinese adults with epilepsy or after neurosurgery were used for external validation. Data on published VPA PPK models were extracted from the literature. Prediction-based diagnostics (such as F20 and F30), simulation-based diagnostics, and Bayesian forecasting were used to evaluate the predictability of models...
August 29, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39183195/reference-guides-for-the-safe-use-of-drugs-during-pregnancy-a-systematic-review-and-comparative-analysis
#7
REVIEW
Xue-Feng Jiao, Panda Qiu, Zheyun Song, Xue Peng, Hailong Li, Linan Zeng, Lingli Zhang
PURPOSE: To comprehensively evaluate and compare all the available reference guides for the safe use of drugs during pregnancy, with the goal of determining the scientificity and reliability of these reference guides. METHODS: We searched PubMed, EMbase, CNKI, Wanfang Database, and VIP database to comprehensively identify the available reference guides. Moreover, we selected 103 drugs based on relevant literatures, and compared the recommendations of each drug from different reference guides...
August 26, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39183194/evaluation-of-pharmacokinetic-target-attainment-and-hematological-toxicity-of-linezolid-in-pediatric-patients
#8
JOURNAL ARTICLE
Manal Abouelkheir, Maram R Aldawsari, Leen Ghonem, Aliyah Almomen, Emad Alsarhani, Sarah Alsubaie, Saeed Alqahtani, Zeyad Kurdee, Abdullah Alsultan
BACKGROUND: Linezolid is commonly used to treat severe and/or resistant Gram-positive infections. Few studies have assessed its pharmacokinetic (PK) target attainment in pediatrics. OBJECTIVE: To evaluate the percentage of pediatrics achieving the PK targets of linezolid with standard dosing regimens and to assess the incidence and risk factors associated with its hematologic toxicity. METHODS: This prospective observational study included pediatric patients aged 0-14 who received linezolid for suspected or proven Gram-positive infections...
August 25, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39168875/correction-to-use-of-antibiotics-in-the-early-covid%C3%A2-19-pandemic-in-poland-the-netherlands-and-spain-from-erraticism-to-more-logic
#9
Aleksandra Opalska, Helga Gardarsdottir, Marcel Kwa, Jadwiga Wójkowska-Mach, Monica Sabate, Maria Elena Ballarin, Mark de Groot, Hubert Leufkens
No abstract text is available yet for this article.
August 22, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39168874/prognostic-effect-of-a-vasopressin-v-2-receptor-antagonist-in-acute-congestive-heart-failure-patients-with-hypoperfusion-the-wet-cold-pattern
#10
JOURNAL ARTICLE
Kenichi Matsushita, Kazumasa Harada, Takamichi Miyamoto, Kiyoshi Iida, Yoshiya Yamamoto, Yasuyuki Shiraishi, Yuji Nagatomo, Hideaki Yoshino, Takeshi Yamamoto, Ken Nagao, Morimasa Takayama
PURPOSE: This study investigated whether the oral vasopressin V2 receptor antagonist tolvaptan has beneficial effects on mortality in real-world congestive heart failure (CHF) patients with hypoperfusion (i.e. the wet-cold pattern), from the viewpoint of cardiorenal syndrome. METHODS: Data on 5511 consecutive CHF patients were extracted from the Tokyo CCU Network data registry. Congestion and hypoperfusion were defined by Nohria-Stevenson clinical profiles at the time of hospitalization...
August 21, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39158691/serious-gaming-as-potential-training-tool-for-recognition-of-adverse-drug-reactions-side-effect-exposure-medical-education-seeme
#11
JOURNAL ARTICLE
Ingmar Bergs, Laura Bell, Sebastian Fedrowitz, Tim Krüger, Martin Lemos, Julia C Stingl, Katja S Just
PURPOSE: The recognition of adverse drug reactions (ADRs) is an important part of daily clinical work. However, medical education in this field is mostly drug-based and does not address adequately the complexity of this field regarding individual risk factors and polypharmacy. This study investigates the potential of the web-based serious game SeeMe (side-effect exposure-medical education) in pharmacological education of medical students to improve the recognition of relevant ADRs. METHODS: One hundred fifty-seven medical students were recruited to evaluate the serious game SeeMe...
August 19, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39158690/evaluation-of-slc6a2-and-cyp2d6-polymorphisms-effects-on-atomoxetine-treatment-in-attention-deficit-and-hyperactivity-disorder
#12
JOURNAL ARTICLE
Ismail Hasan Kole, Pınar Vural, Beste Yurdacan, Adem Alemdar, Caner Mutlu
BACKGROUND: There is insufficient replicated data to establish a relationship between the polymorphisms of SLC6A2 and CYP2D6 and the treatment responses of atomoxetine (ATX) in ADHD. We focused on evaluating the effect of top-line single nucleotide polymorphisms (SNPs) in SLC6A2 and CYP2D6 on the ATX treatment response in attention deficit and hyperactivity disorder (ADHD). METHODS: Of 160 patient records, 34 patients who met the inclusion criteria were evaluated to determine the relationship between genotypes of ten SNPs (six of SLC6A2 and four of CYP2D6) and ATX treatment response...
August 19, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39153087/model-informed-dose-optimization-of-mycophenolic-acid-in-pediatric-kidney-transplant-patients
#13
JOURNAL ARTICLE
Astrid Heida, Nynke G L Jager, Rob E Aarnoutse, Brenda C M de Winter, Huib de Jong, Ron J Keizer, Elisabeth A M Cornelissen, Rob Ter Heine
PURPOSE: We aimed to develop and evaluate a population PK model of mycophenolic acid (MPA) in pediatric kidney transplant patients to aid MPA dose optimization. METHODS: Data were collected from pediatric kidney transplant recipients from a Dutch academic hospital (Radboudumc, the Netherlands). Pharmacokinetic model-building and model-validation analyses were performed using NONMEM. Subsequently, we externally evaluated the final model using data from another academic hospital...
August 17, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39150536/therapeutic-drug-monitoring-for-valproate-deriving-a-novel-formula-for-calculation-of-free-concentration
#14
JOURNAL ARTICLE
Erna Pretorius, Paulina van Zyl, Gina Joubert
BACKGROUND: Monitoring free valproate concentrations, as with other highly protein-bound anticonvulsants, is essential in clinical situations where protein binding may be disrupted. Conversion of measured total concentrations to approximate free concentrations offers a cost-effective alternative. This study evaluated the relationship between total and free valproate concentrations for discordance and the impact of key determinants. A novel formula was devised that incorporates significant variables...
August 16, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39141126/short-term-usage-of-proton-pump-inhibitors-during-admission-was-associated-with-increased-risk-of-rehospitalization-in-critically-ill-patients-with-myocardial-infarction-a-cohort-study
#15
JOURNAL ARTICLE
Jia-De Zhu, Li-Juan Yang, Jian-Nan Zhao, Ping Wang, Yi-Hua Li, Xue-Sha Zhang, Jian-Mei Pan, Meng-Han Jiang, Hai-Ying Yang, Sun-Jun Yin, Gong-Hao He
PURPOSE: Previous studies showed that long-term use of proton pump inhibitors (PPIs) was associated with cardiovascular events. However, the impact of short-term PPI exposure on intensive care unit (ICU) patients with myocardial infarction (MI) remains largely unknown. This study aims to determine the precise correlation between short-term PPI usage during hospitalization and prognostic outcomes of ICU-admitted MI patients using Medical Information Mart for Intensive Care IV database (MIMIC-IV)...
August 14, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39134879/characteristics-of-isoniazid-induced-psychosis-a-systematic-review-of-case-reports-and-case-series
#16
JOURNAL ARTICLE
Keerthanaa B, Rashmi Appaji, Levin Thomas, Tejaswini Baral, Skanda N, Chaithra, Sonal Sekhar M, Kavitha Saravu, Krishna Undela, Mahadev Rao
PURPOSE: Isoniazid, a first-line antitubercular drug, is associated with nervous system adverse drug reactions such as seizures, peripheral neuropathy, and psychosis. This systematic review of case reports and case series aimed to characterize the demographic, social, and clinical factors associated with isoniazid-induced psychosis in patients with active tuberculosis (TB) and those who received isoniazid for latent TB infection (LTBI). METHODS: We comprehensively searched the Embase, PubMed, and Scopus databases to identify relevant studies published between the date of inception of the database and June 2024...
August 13, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39110168/reliability-and-validity-of-the-turkish-version-of-the-medication-practical-barriers-to-adherence-questionnaire-in-patients-with-chronic-diseases
#17
JOURNAL ARTICLE
Nora Samuelyan, Pınar Ay, Zoe Moon, Mesut Sancar, Rob Horne, Betul Okuyan
PURPOSE: The aim of this study was to evaluate the validity and reliability of the Turkish version of the Medication Practical Barriers to Adherence Questionnaire (MPRAQ-TR). METHODS: This is a validation study conducted between August 2022 and March 2023 in the ambulatory services of a secondary care private hospital located in Istanbul, Türkiye, among patients (18 years of age and older) with chronic diseases. After the Turkish translation and cultural adaptation of the MPRAQ, and a pilot think-aloud study, the following psychometric properties were assessed: internal consistency by calculating the Cronbach's alpha coefficient, 2-week test-retest reliability, convergent validity by calculating Spearman's rank correlation between the MPRAQ-TR and the Turkish version of Medication Adherence Report Scale (MARS), and predictive validity by evaluating the association between the MPRAQ-TR score and nonadherence to medications...
August 7, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39102039/efficacy-and-safety-of-ramucirumab-for-gastric-or-gastro-esophageal-junction-adenocarcinoma-a-systematic-review-and-meta-analysis
#18
JOURNAL ARTICLE
Ruiqi Ren, Zhewei Zhang, Shaokun Zhai, Jiahui Yang, BaihaiTihan Tusong, Jingzhou Wang
PURPOSE: Based on the comparison of ramucirumab monoclonal antibody with control treatments in randomized controlled trials, this study aims to elucidate the role of ramucirumab monoclonal antibody in cancer therapy and its potential side effects, providing scientific evidence for clinical treatment. METHODS: PubMed, Embase, Cochrane, and Web of Science were searched systematically to obtain the trials on ramucirumab in the treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma up to April 13, 2023...
August 5, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39073438/drug-administration-via-feeding-tubes-a-procedure-that-carries-risks-systematic-identification-of-critical-factors-based-on-commonly-administered-drugs-in-a-cohort-of-stroke-patients
#19
REVIEW
Jana Sommerfeldt, Hannes Sartorius, Bettina von Sarnowski, Sandra Klein, Christoph A Ritter
PURPOSE: Drug administration via feeding tubes is considered a process with many uncertainties. This review aimed to give a comprehensive overview of data available on feeding tube application and to carry out risk assessments for drug substances commonly administered to stroke patients. METHODS: Drugs frequently administered via feeding tubes were identified through a retrospective analysis of discharge letters from a stroke unit. Physicochemical, pharmacokinetic, and stability properties of these drugs and data on drug-enteral nutrition interactions were systematically searched for in the European Pharmacopoeia, Hagers Handbook of Pharmaceutical Practice, Birchers clinical-pharmacological data compilation, and the Martindale Complete Drug Reference, as well as from databases including DrugBank, DrugDex, PubChem, Google Scholar, and PubMed...
July 29, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/39052049/neuronal-toxicity-of-monoclonal-antibodies-mabs-an-analysis-of-post-marketing-reports-from-fda-adverse-event-reporting-system-faers-safety-database
#20
JOURNAL ARTICLE
Nitin Kumar, Vivekanandan Kalaiselvan, Mandeep Kumar Arora
BACKGROUND: Monoclonal antibodies (mAbs) are pivotal in treating various diseases, including cancers and autoimmune disorders. Despite their therapeutic benefits, mAb therapy has been associated with neurological toxicity. OBJECTIVES: This study aimed to assess the occurrence of neuronal toxicity associated with mAbs, utilizing data from the FDA Adverse Event Reporting System (FAERS) safety database. The study also sought to delineate the medical characteristics of the reported cases...
July 25, 2024: European Journal of Clinical Pharmacology
journal
journal
25237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.